Related references
Note: Only part of the references are listed.Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study
Sarah C. J. Jorgensen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia A Randomized Clinical Trial
Steven Y. C. Tong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
Erin K. McCreary et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Kyle C. Molina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis
Pramodini B. Kale-Pradhan et al.
PHARMACOTHERAPY (2020)
Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli
Ryan L. Crass et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
Kasper Iversen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Matthew Geriak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Long-Term Outcomes of Partial Oral Treatment of Endocarditis
Henning Bundgaard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study
Gilbert Habib et al.
EUROPEAN HEART JOURNAL (2019)
DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
Carmen Hidalgo-Tenorio et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2019)
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
Gilbert Habib et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2019)
Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
Selma Tobudic et al.
CLINICAL INFECTIOUS DISEASES (2018)
A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis
Maya Beganovic et al.
CLINICAL INFECTIOUS DISEASES (2018)
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Helmut Baumgartner et al.
EUROPEAN HEART JOURNAL (2017)
2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary
Gosta B. Pettersson et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2017)
Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry
K. Malizos et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
2015 ESC Guidelines for the management of infective endocarditis
Gilbert Habib et al.
EUROPEAN HEART JOURNAL (2015)
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin
O. Gasch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
George Sakoulas et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
High-Dose Daptomycin Therapy for Staphylococcal Endocarditis and When to Apply It
Jordan R. Smith et al.
CURRENT INFECTIOUS DISEASE REPORTS (2014)
Impact of a Multidisciplinary Management Strategy on the Outcome of Patients With Native Valve Infective Endocarditis
Fabio Chirillo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis
Manuela Carugati et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study
Kyle P. Murray et al.
CLINICAL INFECTIOUS DISEASES (2013)
A Current Perspective on Daptomycin for the Clinical Microbiologist
Romney M. Humphries et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience
R. Andrew Seaton et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Daptomycin for the treatment of infective endocarditis: results from a European registry
Pascal M. Dohmen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
George Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dramatic Reduction in Infective Endocarditis-Related Mortality With a Management-Based Approach
Elisabeth Botelho-Nevers et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates
Susan J. Rehm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Infective endocarditis in the real world: the italian registry of infective endocarditis (Registro Italiano Endocardite Infettiva RIEI)
Enrico Cecchi et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2008)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)